Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peanut oral immunotherapy protects patients from accidental allergic reactions to peanut.
Trendelenburg V, Blumchen K, Bellach J, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Holzhauser T, Röder M, Niggemann B, Beyer K. Trendelenburg V, et al. Among authors: gruebl a. J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2437-2441.e3. doi: 10.1016/j.jaip.2020.03.043. Epub 2020 Apr 15. J Allergy Clin Immunol Pract. 2020. PMID: 32304836 No abstract available.
Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Holzhauser T, Roeder M, Rosenfeld L, Hartmann O, Niggemann B, Beyer K. Blumchen K, et al. Among authors: gruebl a. J Allergy Clin Immunol Pract. 2019 Feb;7(2):479-491.e10. doi: 10.1016/j.jaip.2018.10.048. Epub 2018 Nov 10. J Allergy Clin Immunol Pract. 2019. PMID: 30423449 Clinical Trial.
Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
Blumchen K, Beder A, Beschorner J, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Niggemann B, Wahn U, Beyer K. Blumchen K, et al. Among authors: gruebl a. J Allergy Clin Immunol. 2014 Aug;134(2):390-8. doi: 10.1016/j.jaci.2014.03.035. Epub 2014 May 13. J Allergy Clin Immunol. 2014. PMID: 24831438 Clinical Trial.
A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. Rolinck-Werninghaus C, et al. Among authors: gruebl a. Allergy. 2004 Dec;59(12):1285-93. doi: 10.1111/j.1398-9995.2004.00627.x. Allergy. 2004. PMID: 15507097 Clinical Trial.
Effect of exclusive breast-feeding and early solid food avoidance on the incidence of atopic dermatitis in high-risk infants at 1 year of age.
Schoetzau A, Filipiak-Pittroff B, Franke K, Koletzko S, Von Berg A, Gruebl A, Bauer CP, Berdel D, Reinhardt D, Wichmann HE; German Infant Nutritional Intervention Study Group. Schoetzau A, et al. Among authors: gruebl a. Pediatr Allergy Immunol. 2002 Aug;13(4):234-42. doi: 10.1034/j.1399-3038.2002.01050.x. Pediatr Allergy Immunol. 2002. PMID: 12390439